home / stock / skye / skye news


SKYE News and Press, Skye Bioscience Inc Com From 05/30/24

Stock Information

Company Name: Skye Bioscience Inc Com
Stock Symbol: SKYE
Market: OTC
Website: skyebioscience.com

Menu

SKYE SKYE Quote SKYE Short SKYE News SKYE Articles SKYE Message Board
Get SKYE Alerts

News, Short Squeeze, Breakout and More Instantly...

SKYE - Russell 3000: Tecnoglass, Skye Bioscience among industrial additions; Nikola, Workhorse among deletions

2024-05-30 13:35:28 ET More on CRH, Microvast Holdings, etc. Workhorse Group Inc. (WKHS) Q1 2024 Earnings Call Transcript CRH Is Poised To Benefit From A Major Growth Cycle Pagaya: Patience Should Pay Off Nikola discloses order of 100 hydrogen fuel cell truck...

SKYE - Skye Bioscience Highlights Novel Synthetic Cannabinoid-based Library Capable of Modulating the Endocannabinoid System to Treat Ocular Diseases at ARVO 2024 Annual Meeting

SAN DIEGO, May 10, 2024 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel classes of therapeutic drugs that modulate the endocannabinoid system (ECS), today a...

SKYE - Skye Bioscience Moves to Nasdaq, Hits Milestone in Clinical Program

--News Direct-- Skye Bioscience CEO Punit Dhillon joined Steve Darling from Proactive to share news announcing the company's uplisting of its common stock to the Nasdaq stock exchange, trading under the ticker symbol "SKYE." This achievement signifies a significant milestone for the compa...

SKYE - Skye Bioscience to Present Two Posters at Association for Research in Vision and Ophthalmology (ARVO) 2024 Annual Meeting

SAN DIEGO, April 30, 2024 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel classes of therapeutic drugs that modulate the endocannabinoid system, today annou...

SKYE - Skye Bioscience to Present at Upcoming Investment Conferences

SAN DIEGO, April 23, 2024 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel classes of therapeutic drugs that modulate the endocannabinoid system, today annou...

SKYE - These 3 Biotech Stocks Are Up 269% in 2024. Is There More to Come?

2024-04-16 13:19:09 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Investors looking for a white-knuckle ride can easily find one by buying biotech stocks . There is a certain thrill in investing in a company making actual life-or-death decisions with drug...

SKYE - Top 10 stocks with upwards and downwards daily percentage change - Piper Sandler

2024-04-12 11:34:12 ET More on S&P 500 Index: Sticking With The More Optimistic View Where We Stand Sorry Campers, The Fed Is Not Riding To The Rescue Nasdaq, S&P, Dow slip as major banks kick off earnings season Nasdaq, S&P climb, Dow end...

SKYE - Skye Bioscience to uplist to Nasdaq Global Market

2024-04-10 08:09:25 ET More on Skye Bioscience Skye Bioscience announces $50M private placement Seeking Alpha’s Quant Rating on Skye Bioscience Read the full article on Seeking Alpha For further details see: Skye Bioscience to uplist to Nasdaq Glob...

SKYE - Skye Bioscience Uplists to The Nasdaq Global Market

SAN DIEGO, April 10, 2024 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (OTCQB: SKYE) (“Skye” or the "Company"), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel classes of therapeutic drugs that modulate the endocannabinoid sys...

SKYE - Skye Bioscience looks to raise $40M in a private placement equity

2024-03-11 09:29:27 ET More on Skye Bioscience Skye Bioscience announces $50M private placement Seeking Alpha’s Quant Rating on Skye Bioscience Read the full article on Seeking Alpha For further details see: Skye Bioscience looks to raise $40M in a...

Previous 10 Next 10